Menu
Not yet recruiting NCT07090109

PITCH - Impacting Hereditary Cancer Testing

No phase Interventional Ovarian Cancer Genetic Testing Genetic Counseling

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Genetic testing education video.
Who it may be relevant to
Registry conditions: Ovarian Cancer, Genetic Testing, Genetic Counseling. Basic parameters: from 18 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Partnering to Impact Testing in the Commonwealth for Hereditary Cancers (PITCH)

Overview

The goal of this clinical trial is to assess patients' knowledge and attitudes about genetic testing before and after viewing an educational video. The main questions it aims to answer are: * Did the video change participants' knowledge and attitudes about genetic testing? * Did participants make an informed choice about pursuing genetic testing? Participants will: * Complete a baseline survey * View educational video * Complete follow-up survey

Interventions

  • Behavioral Genetic testing education video
    patient education video about genetic testing for hereditary cancers

Primary outcome measures

  • Change in Multi-Dimensional Measure of Informed Choice (MMIC) - Cancer Knowledge Scale [Time frame: Baseline and post intervention (approximately 30 minutes)]
Secondary outcome measures (1)
  • Number of participants completing genetic testing [Time frame: 90 days]

Eligibility criteria

Inclusion criteria

  • diagnosed with a cancer that can be associated with hereditary forms of cancer

Exclusion criteria

  • previously undergone multi-gene panel testing for hereditary cancers

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Other

Study locations

United States · 1 center
  • University of Kentucky — Lexington

Identifiers

NCT: NCT07090109 · 98088

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗